Convulsions Associated with the Use of a Synthetic Cannabinoid Product

Journal of Medical Toxicology

Volumn 8, Issue 1, 2012, Pages 62-64

  Schneir, Aaron B ^a   Baumbacher, Todd ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

AM 2201; Cannabinoids; Convulsions; JWH; Spice

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CANNABINOID; MIDAZOLAM;

ADULT; ARTICLE; CANNABIS SMOKING; CASE REPORT; CONFUSION; CONVULSION; DISEASE ASSOCIATION; DRUG ABUSE; DRUG EXPOSURE; DRUG SCREENING; HUMAN; MALE; RECREATION; VITAL SIGN; VOMITING;

ADULT; CANNABINOIDS; HUMANS; MALE; SEIZURES; YOUNG ADULT;

EID: 84857796142     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-011-0182-2     Document Type: Article

References (24)

1. Vardakou I, Pistos C, Spiliopoulou C (2010) Spice drug as a new trend: mode of action, identification and legislation. Toxicol Lett 197: 157-162.
2. United States Drug Enforcement Administration. Chemicals used in "Spice" and "K2" type products now under federal control and regulation. Available at http://www. justice. gov/dea/pubs/pressrel/pr030111. html. Accessed on May 4, 2011.
3. Simmons JR, Skinner CG, Williams J, Kang CS, Schwartz MD, Wills BK (2011) Intoxication from smoking "spice". Ann Emerg Med 57: 187-188, letter.
4. Banerji S, Deutsch CM, Bronstein AC (2010) Spice ain't so nice:[abstract]. Clin Toxicol 48: 632.
5. Bebarta VS, Varney S, Sessions D et al (2010) Spice: a new "legal" herbal mixture abused by young active duty military personnel: [abstract]. Clin Toxicol 48: 632.
6. Simmons J, Cookman L, Kang C, Skinner C (2011) Three caes of "spice" exposure. Clin Toxicol 49: 431-433.
7. Schneir AB, Cullen J, Ly BT (2011) "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med 40: 296-299.
8. Vearrier D, Osterhoudt KC (2010) A teenager with agitation. Pediatr Emerg Care 26(6): 462-464.
9. Canning JC, Ruha A-M, Pierce R, Torrey M, Reinhart SJ (2010) Severe gi distress after smoking JWH-018: [abstract]. Clin Toxicol 48: 618.
10. Muller H, Sperling W, Kohrmann M et al (2010) The synthetic cannabinoid spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res 118: 309-310.
11. Ng SK, Brust JC, Hauser WA, Susser M (1990) Illicit drug use and the risk of new-onset seizures. Am J Epidemiol 132: 47-57.
12. Gordon E, Devinsky O (2001) Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia 42: 1266-1272.
13. Keeler MH, Reifler CB (1967) Grand mal convulsions subsequent to marijuana use. Case report. Dis Nerv Syst 28: 474-475.
14. Bonkowsky JL, Sarco D, Pomeroy SL (2005) Ataxia and shaking in a 2-year-old girl: acute marijuana intoxication presenting as seizure. Pediatr Emerg Care 21(8): 527-528.
15. Spadari M, Glaizal M, Tichadou L, Blanc I, Drouet G, Aymard I, De Haro L, Hayek-Lanthois M, Arditti J (2009) Accidental cannabis poisoning in children: experience of the Marseille poison center. Presse Med 38(11): 1563-1567.
16. Every-Palmer S (2011) Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend 117: 152-157.
17. Dresen S, Ferreiros N, Putz M, Westphal F, Zimmerman R, Auwarter V (2010) Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom 45: 1186-1194.
18. Howlett AC, Breivogel CS, Childers SR, DEADwyler SA, Hampson RE, Porrino LJ (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47: 345-358.
19. Seely KA, Pratheer PL, James LP, Moran JH (2011) Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? Mol Interv 11: 36-51.
20. Hill AJ, Weston SE, Jones NA, Smith I, Bevan SA, Williamson EM, Stephens GJ, Williams CM, Whalley BJ (2010) Δ-9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats. Epilepsia 51: 1522-1532.
21. Karler R, Turkanis SA (1981) The cannabinoids as potential antiepileptics. J Clin Pharmacol 21: 437S-448S.
22. Consroe P, Martin A, Singh V (1981) Antiepileptic potential of cannabidiol analogs. J Clin Pharmacol 21: 428S-436S.
23. Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R (1980) Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21: 175-185.
24. Carlini EA, Cunha JM (1981) Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol 21: 417S-427S.